Abstrakt: |
Keywords: Antiinfectives; Antituberculosis Agents; Drugs and Therapies; HIV/AIDS; Health and Medicine; Hydrazines; Immune System Diseases and Conditions; Infectious Disease; Isoniazid; Isoniazid Therapy; Mycobacterium Infections; Nicotinic Acid Derivatives; Pharmaceuticals; Primate Lentiviruses; RNA Viruses; Retroviridae; Risk and Prevention; Tuberculosis; Vertebrate Viruses; Viral Sexually Transmitted Diseases and Conditions EN Antiinfectives Antituberculosis Agents Drugs and Therapies HIV/AIDS Health and Medicine Hydrazines Immune System Diseases and Conditions Infectious Disease Isoniazid Isoniazid Therapy Mycobacterium Infections Nicotinic Acid Derivatives Pharmaceuticals Primate Lentiviruses RNA Viruses Retroviridae Risk and Prevention Tuberculosis Vertebrate Viruses Viral Sexually Transmitted Diseases and Conditions 52 52 1 04/03/23 20230403 NES 230403 2023 APR 3 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- A new study on HIV/AIDS is now available. Antiinfectives, Antituberculosis Agents, Drugs and Therapies, HIV/AIDS, Health and Medicine, Immune System Diseases and Conditions, Infectious Disease, Isoniazid, Isoniazid Therapy, Hydrazines, Mycobacterium Infections, Nicotinic Acid Derivatives, Pharmaceuticals, Primate Lentiviruses, RNA Viruses, Retroviridae, Risk and Prevention, Tuberculosis, Vertebrate Viruses, Viral Sexually Transmitted Diseases and Conditions. [Extracted from the article] |